Yong Pei

2.1k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Yong Pei is a scholar working on Dermatology, Rheumatology and Pharmacology. According to data from OpenAlex, Yong Pei has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 5 papers in Rheumatology and 4 papers in Pharmacology. Recurrent topics in Yong Pei's work include Dermatology and Skin Diseases (4 papers), Inflammatory mediators and NSAID effects (4 papers) and NF-κB Signaling Pathways (4 papers). Yong Pei is often cited by papers focused on Dermatology and Skin Diseases (4 papers), Inflammatory mediators and NSAID effects (4 papers) and NF-κB Signaling Pathways (4 papers). Yong Pei collaborates with scholars based in United States, Denmark and Germany. Yong Pei's co-authors include Jeffrey B. Travers, Takahiro Takano, Maiken Nedergaard, Michael D. Southall, Nanhong Lou, Anna L. R. Xavier, Steven A. Goldman, Tao Li, Grant D. Nicol and Lane K. Bekar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Neuroscience.

In The Last Decade

Yong Pei

16 papers receiving 1.6k citations

Hit Papers

Adenosine A1 receptors me... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Pei United States 15 486 386 373 283 227 17 1.7k
Wen‐Li Mi China 29 220 0.5× 814 2.1× 364 1.0× 133 0.5× 335 1.5× 68 1.8k
Gisela Segond von Banchet Germany 24 100 0.2× 1.3k 3.3× 471 1.3× 109 0.4× 177 0.8× 44 2.3k
Changyu Jiang China 25 73 0.2× 775 2.0× 430 1.2× 165 0.6× 167 0.7× 62 1.6k
Niels Eijkelkamp Netherlands 28 94 0.2× 1.4k 3.6× 1.1k 3.0× 178 0.6× 181 0.8× 80 2.9k
Han‐Rong Weng United States 33 70 0.1× 1.8k 4.8× 752 2.0× 341 1.2× 63 0.3× 57 3.0k
Elizabeth K. Joseph United States 23 169 0.3× 1.6k 4.1× 675 1.8× 71 0.3× 45 0.2× 30 2.5k
Andy Dray Canada 23 81 0.2× 1.1k 2.9× 913 2.4× 76 0.3× 195 0.9× 34 2.6k
De‐Li Cao China 21 70 0.1× 1.0k 2.7× 436 1.2× 269 1.0× 155 0.7× 30 1.7k
Bao‐Chun Jiang China 24 81 0.2× 1.2k 3.1× 622 1.7× 336 1.2× 189 0.8× 49 2.1k
Hjalte Holm Andersen Denmark 23 70 0.1× 425 1.1× 370 1.0× 77 0.3× 52 0.2× 57 1.5k

Countries citing papers authored by Yong Pei

Since Specialization
Citations

This map shows the geographic impact of Yong Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Pei more than expected).

Fields of papers citing papers by Yong Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Pei. The network helps show where Yong Pei may publish in the future.

Co-authorship network of co-authors of Yong Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Pei. A scholar is included among the top collaborators of Yong Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Pei. Yong Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Meihua, et al.. (2025). Regulation mechanism of curcumin mediated inflammatory pathway and its clinical application: a review. Frontiers in Pharmacology. 16. 1642248–1642248.
2.
Lou, Nanhong, Takahiro Takano, Yong Pei, et al.. (2016). Purinergic receptor P2RY12-dependent microglial closure of the injured blood–brain barrier. Proceedings of the National Academy of Sciences. 113(4). 1074–1079. 263 indexed citations
3.
Chen, Michael, Takumi Fujita, Qiwu Xu, et al.. (2010). Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nature Neuroscience. 13(7). 883–888. 614 indexed citations breakdown →
4.
Thirunavukkarasu, Kannan, Yong Pei, & Tao Wei. (2007). Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter. Molecular Biology Reports. 34(4). 225–231. 52 indexed citations
5.
Pei, Yong, Anita K. Harvey, Xiaopeng Yu, Srinivasan Chandrasekhar, & Kannan Thirunavukkarasu. (2006). Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthritis and Cartilage. 14(8). 749–758. 53 indexed citations
6.
Thirunavukkarasu, Kannan, Yong Pei, Terry L. Moore, et al.. (2006). Regulation of NFATc2 gene expression by the transcription factor Runx2. Molecular Biology Reports. 34(1). 1–10. 10 indexed citations
7.
Thirunavukkarasu, Kannan, Yong Pei, Terry L. Moore, et al.. (2006). Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines. Biochemical and Biophysical Research Communications. 345(1). 197–204. 50 indexed citations
8.
Marathe, Gopal K., Christopher N. Johnson, Steven D. Billings, et al.. (2005). Ultraviolet B Radiation Generates Platelet-activating Factor-like Phospholipids underlying Cutaneous Damage. Journal of Biological Chemistry. 280(42). 35448–35457. 82 indexed citations
9.
Southall, Michael D., et al.. (2003). Activation of Epidermal Vanilloid Receptor-1 Induces Release of Proinflammatory Mediators in Human Keratinocytes. Journal of Pharmacology and Experimental Therapeutics. 304(1). 217–222. 237 indexed citations
10.
Li, Tao, Michael D. Southall, Qiaofang Yi, et al.. (2003). The Epidermal Platelet-activating Factor Receptor Augments Chemotherapy-induced Apoptosis in Human Carcinoma Cell Lines. Journal of Biological Chemistry. 278(19). 16614–16621. 29 indexed citations
11.
Parinandi, Narasimham L., et al.. (2003). Hyperoxia Alters Phorbol Ester-Induced Phospholipase D Activation in Bovine Lung Microvascular Endothelial Cells. Antioxidants and Redox Signaling. 5(2). 217–228. 17 indexed citations
12.
Pei, Yong, Michael D. Southall, John M. Johnston, et al.. (2002). Identification of Platelet-Activating Factor Acetylhydrolase II in Human Skin. Journal of Investigative Dermatology. 119(4). 913–919. 41 indexed citations
13.
Southall, Michael D., Jason S. Isenberg, Harikrishna Nakshatri, et al.. (2001). The Platelet-activating Factor Receptor Protects Epidermal Cells from Tumor Necrosis Factor (TNF) α and TNF-related Apoptosis-inducing Ligand-induced Apoptosis through an NF-κB-dependent Process. Journal of Biological Chemistry. 276(49). 45548–45554. 39 indexed citations
14.
Pei, Yong, et al.. (2000). Evidence for Involvement of the Epidermal Platelet-Activating Factor Receptor in Ultraviolet-B-Radiation-Induced Interleukin-8 Production. Journal of Investigative Dermatology. 115(2). 267–272. 19 indexed citations
15.
Dy, Lady C., Yong Pei, & Jeffrey B. Travers. (1999). Augmentation of Ultraviolet B Radiation-induced Tumor Necrosis Factor Production by the Epidermal Platelet-activating Factor Receptor. Journal of Biological Chemistry. 274(38). 26917–26921. 47 indexed citations
16.
Travers, Jeffrey B., Robert C. Murphy, Christopher A. Johnson, et al.. (1998). Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. Prostaglandins & Other Lipid Mediators. 56(5-6). 305–324. 23 indexed citations
17.
Pei, Yong, Robert C. Murphy, Christopher A. Johnson, et al.. (1998). Activation of the Epidermal Platelet-Activating Factor Receptor Results in Cytokine and Cyclooxygenase-2 Biosynthesis. The Journal of Immunology. 161(4). 1954–1961. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026